Investor Devo

Just a guy trying to learn as much as possible. All tweets are for entertainment purposes and should not be taken as financial advice.

[Theta Warrior @ThetaWarrior]

$NVDA Net Options Delta: +2.3M shares

[Robert Griffin III @RGIII]

My God, this Presidential debate proves that we need younger presidential candidates.

[Investor Devo @InvestorDevo]

@theficouple Analyze

[BriaCell Therapeutics Corp. @BriaCell]

BriaCell is thrilled to announce a new remarkable responder in our Phase 2 study of the Bria-IMT™ combination regimen. For additional details, visit: https://t.co/F5ikuLy3nn $BCTX $BCTXW

[Investor Devo @InvestorDevo]

@WallStreetSilv Social Security

[BrainStorm @BrainstormCell]

Details regarding the #FDA #AdComm for #NurOwn are now posted and the docket is open for public comments. Read more about the Advisory Committee Meeting September 27, 2023 Announcement - 09/27/2023 | FDA https://t.co/FOBCVeytxV

[Investor Devo @InvestorDevo]

It’s disappointing to know how many “small” biotech companies with viable treatments for severe diseases have been ruined by @FDACBER. $BCLI $BCTX

[Brian Wallach @bsw5020]

I, for one, believe that every member of the ALS community - patients, advocates and organizations - should be in favor of the NurOwn AdComm.

It is finally a chance to have a transparent assessment of the science and the real world evidence.

[Investor Devo @InvestorDevo]

Great news for PALS https://t.co/9jHg1vY4nm $BCLI

[AZ Latina ☮️🌊🟦 @aVoice4ALS]

People receiving #NurOwn told @FDACBER that it halted their paralysis

🔹P2 - 2015
🔹P3 - 2017-2019
🔹RTT - 2018-2020
🔹EAP - 2021-2022

Clinical Trial Data confirms #RealWorldEvidence that #NurOwnWorked 7 yrs & 42k deaths ago

People w #ALS have a right to testify

#SomeIsEnough

[Yenom @Yenom99]

$ILUS Really hoping to hear something about this before or at the Annual Shareholder Meeting on Friday.

$QIND #ERT

@ILUS_INTL @BackwellJp @NicolasLink

[Yenom @Yenom99]

$ILUS Officially two weeks until the @ILUS_INTL Annual Shareholder Meeting in Miami.

“A storm is brewing” and “celebration” have been phrases used by the company over the past couple months.

A lot of people are waiting on execution and finalizations.

@BackwellJp @NicolasLink

[Investor Devo @InvestorDevo]

#NurownWorks $bcli

[C Lebovits @Cylebo]

Sharing with all, as many were asking about the Type A meeting:
https://t.co/b3SFcRDXkr

[Brian Wallach @bsw5020]

We are concerned that @US_FDA has a different view of regulatory flexibility than CDER, and a lack of consistency between @US_FDA review divisions. We are asking for an #AdCom to debate this promising therapy, #NurOwn. https://t.co/K8YWFwDceV

[Moon Market @MoonMarket_]

$ILUS ILUS Confirms Strong Third Quarter Results With Increases in Revenue and Net Profit

· Revenue: $20,419,421
· Net Profit: $1,187,494
· Assets: $77,299,258

https://t.co/AOgFYdF9cU

[Investor Devo @InvestorDevo]

@ChairmanOtc @Multi_Pennies $BCLI company with ALS therapy. Beaten down and will have an Adcom hearing with FDA soon. ALS community backs #Nurown big time.

[Investor Devo @InvestorDevo]

$CAPC with another great product!

[Capstone Companies, Inc. @CAPC_Capstone]

Connected Chef ready for 2023! More to follow!

[Investor Devo @InvestorDevo]

@stockplayer30 George looks to be part of the Bull Head acquisition. Barbara looks to be part of the Georgia Fire & Rescue. Can’t find anything on Sheila, too generic of a name unfortunately. $ILUS

[Investor Devo @InvestorDevo]

@stockplayer30 Now to find out where those people being issued shares work(ed) at. Let the search begin

[NanoMan1 @NanoMan100]

$INTK INTK has Sales of $15.4M in the first 3 quarters of 2022 and about $6.5 million in NET INCOME. Record Sales, Record Net Income, Record Shareholders Equity 3 quarters in a row. The Middle East projects haven't even started yet! Please retweet. https://t.co/u8bGVP9ijP